Drug
SLS-005 clinical trials
Also written SLS-005.
- studies test it
- 4
- open now
- 0
- in phase 3
- 3
- first study started
- 2020
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 2
Often tested with
Tested in the same studies.
Zilucoplan (1) · AZD3241 (1) · CNM-Au8 (1) · Pridopidine (1) · Fosigotifator sodium tromethamine (1) · Fosigotifator (1) · Evetifator (1) · NUZ-001 (1)
Studies
Open first, then newest update. How each study uses SLS-005 is read from its arms, and is right about nine times in ten.
Testing it · 4
- HEALEY ALS Platform Trial - Master ProtocolActive, not recruitingPhase 2/3Merit E. Cudkowicz, MDNCT04297683Written as SLS-005 Trehalose
- HEALEY ALS Platform Trial - Regimen E SLS-005 - TrehaloseCompletedPhase 2/3Merit E. Cudkowicz, MDNCT05136885Written as SLS-005
- STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar AtaxiaTerminatedPhase 2/3Seelos Therapeutics, Inc.NCT05490563Written as SLS-005
- SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's DiseaseWithdrawnPhase 2Seelos Therapeutics, Inc.NCT05332678Written as SLS-005 - Once Weekly